Sumsuzzman D M, Wang Z, Langley JM, Moghadas SM, Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: A systematic review and meta-analysis, The Lancet Child & Adolescent Health 2025, 9: 393-403.
Du Z, Pandey A, Moghadas SM, Bai Y, Wang L, Matrajt L, Singer BH, Galvani AP, Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults, Nature Medicine 2025, 31(2): 647-652.
Moghadas SM, Shoukat A, Bawden CE, Langley JM, Singer BH, Fitzpatrick MC, Galvani AP. Cost-effectiveness of prefusion F protein-based vaccines against respiratory syncytial virus disease for older adults in the United States. Clinical Infectious Diseases. 2024, 78(5): 1328-1335.
Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM, Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: A simulation study, The Lancet Regional Health - Americas 2023, 28: 100629.
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP, The implications of silent transmission for the control of COVID-19 outbreaks, Proceedings of the National Academy of Sciences USA 2020, 117(30): 17513–17515.
For citation of our published studies, visit Google Scholar
Vilches TN, Nourbakhsh S, Zhang K, Juden-Kelly L, Cipriano LE, Langley JM, Sah P, Galvani AP, Moghadas SM, Multifaceted strategies for the control of COVID-19 outbreaks in long-term care facilities in Ontario, Canada, Preventive Medicine 2021, 148: 106564.
Moghadas SM, Fitzpatrick MC, Shoukat A, Zhang K, Galvani AP, Simulated identification of silent COVID-19 infections among children and estimated future infection rates with vaccination, JAMA Network Open 2021, 4(4): e217097.
Moghadas SM, Vilches TN, Zhang K, Nourbakhsh S, Sah P, Fitzpatrick MC, Galvani AP, Evaluation of COVID-19 vaccination strategies with a delayed second dose, PLoS Biology 2021, 19(4): e3001211.
Wells CR, Townsend JP, Pandey A, Moghadas SM, Krieger G, Singer BH, McDonald RH, Fitzpatrick MC, Galvani AP, Optimizing COVID-19 quarantine and testing strategies, Nature Communications 2021, 21: 356.
Zhang K, Shoukat A, Crystal W, Langley JM, Galvani AP, Moghadas SM,Routine saliva testing for the identification of silent COVID-19 infections in healthcare workers, Infection Control Hospital Epidemiology 2021, 42(10), 1189-1193.
Moghadas SM, Vilches TN, Zhang K, Wells CR, Shoukat A, Singer BH, Fitzpatrick MC, Meyers LA, Neuzil K, Langley JM, Galvani AP, The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States, Clinical Infectious Diseases 2021, 73(12): 2257–2264.
Zhang K, Misra A, Kim PJ, Moghadas SM,Langley JM, Smieja M, Rapid disappearance of influenza following the implementation of COVID-19 mitigation measures in Hamilton, Ontario, Canada Communicable Disease Report 2021, 47(4): 202–208.
Tariq M, Haworth-Brockman M, Moghadas SM, Ten years of Pan-InfORM: modelling research for public health in Canada, AIMS Public Health 2021, 8(2): 265–274.
Zhang K, Vilches TN, Tariq M, Galvani AP, Moghadas SM, The impact of mask-wearing and shelter-in-place on COVID-19 outbreaks in the United States, International Journal of Infectious Diseases 2020, 101: 334-341.
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP, The implications of silent transmission for the control of COVID-19 outbreaks, Proceedings of the National Academy of Sciences USA 2020, 117(30): 17513–17515.